1Wang Y, Liu DH, Fan ZP, et al. Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study[J]. ClinTransplant, 2012, 26(4): 635-643.
2Velardi A, Rugged L, Capanni M, et al. Impact of NK cell aUoreaetivity on miamatched haemopoietic transplantation: an update on donor selection criteria and on transplantation outcomes[J]. Blood, 2003, 102(11): 153A.
3Ljunggren HG, Karre IC Inseatr.h of the. missing self: MHC molules and NK cell recognition[J]. Immunol Today, 1990, 11(7): 237-244.
4Thielens A, Vivier E, Romagnd F.NK cell MHC class I specific receptors (KIP,): from biology to clinical interrelation[J]. Curt Opin Immunol, 2012, 24(2): 239-245.
5Ruggeri L, Capanni M, Urhani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants[J]. Science, 2002, 295(5562): 2097-2100.
6Rugged L, Mancusi A, Capanni M, et al. Donor natural killer cell allorecognition of missing self in haploidenfical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value[J]. Blood, 2007, 110(1): 433-440.
7Velardi A, Rugged L Capaani M, ct al. Immunothoapy with allorcactive natural killer cells in haploideaXical hammtopoietic tnmsplantation[J]. Hcmatol J, 2004, 5 Suppl 3: S87-90.
8Da Wanming, Da Yong. Tumorablative AUogeneic Hematopoietic Cell Transplantation in the Treatment of High-risk and Refi'actory Leukemia-New Concepts and Clinical Practice[M]//Tancr Demircr. In Innovation of Stem Cell Transplantation, In Tech, 2013: 257-271.
